Reported results
- Net sales were $33.0 million in Q3 2026 compared to $30.5 million in Q3 2025.
- Net income was $637 thousand, or $0.21 per diluted share, in Q3 2026 compared to a net loss of $(146) thousand, or $(0.05) per diluted share, in Q3 2025.
- Adjusted EBITDA was $2.0 million in Q3 2026 compared to $1.3 million in Q3 2025.
- EBITDA was $1.7 million in Q3 2026 compared to $1.3 million in Q3 2025.
- Total backlog was $92.8 million as of September 30, 2026, compared to $31.3 million as of September 30, 2025.
- 90-day backlog was $31.5 million as of September 30, 2026, compared to $31.3 million as of September 30, 2025.
Price and volatility reaction
Source
The figures above come from the earnings release the company filed with the SEC on 2026-11-12 (8-K, Item 2.02). Read the original filing on sec.gov.
